CTRX Insider Trading Activity and SEC Form 4 Filings
CTRX insider trading summary
No open-market insider purchases or sales of Cornerstone Therapeutics Inc (CTRX) have been reported on SEC Form 4 in the past 12 months.
Latest CTRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 12, 2012 | Farmaceutici SpA Chiesi | 10% Owner | Buy | $20K (3,400 @ $5.85) |
| Feb 22, 2006 | Thomas Feldman | Chief Business Officer | Sell | $83K (7,500 @ $11.00) |
| Feb 22, 2006 | Thomas Feldman | Chief Business Officer | Sell | $139K (12,500 @ $11.12) |
| Feb 22, 2006 | Thomas Feldman | Chief Business Officer | Sell | $165K (15,000 @ $11.00) |
| Oct 19, 2005 | Ansbert Gadicke | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
| Oct 19, 2005 | Luke Evnin | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
| Oct 19, 2005 | Dennis Henner | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
| Oct 19, 2005 | Mpm Bioventures III Gmbh & Co | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
| Oct 19, 2005 | Mpm Bioventures III Parallel Fund | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
| Oct 19, 2005 | Mpm Asset Management Investors 2003 Bviii LLC | 10% Owner | Sell | $2.2M (170,563 @ $13.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.